LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1235 | 636 | 4474 | 0.1421 | -0.3009 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 1235 | 579 | 4578 | 0.1265 | -0.3306 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 1235 | 744 | 4929 | 0.1509 | -0.2246 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 1 | I02 | 72 | hr | 1235 | 781 | 4355 | 0.1793 | -0.2232 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 2 | I02 | 72 | hr | 1235 | 413 | 4277 | 0.0966 | -0.4577 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 3 | I02 | 72 | hr | 1235 | 689 | 4583 | 0.1503 | -0.2659 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 1 | D02 | 72 | hr | 1235 | 639 | 4474 | 0.1428 | -0.2991 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 2 | D02 | 72 | hr | 1235 | 653 | 4578 | 0.1426 | -0.2866 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 1235 | 723 | 4929 | 0.1467 | -0.2356 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 1 | I01 | 72 | hr | 1235 | 468 | 4355 | 0.1074 | -0.4140 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 2 | I01 | 72 | hr | 1235 | 229 | 4277 | 0.0535 | -0.6099 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 3 | I01 | 72 | hr | 1235 | 613 | 4583 | 0.1337 | -0.3099 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 1 | D01 | 72 | hr | 1235 | 562 | 4474 | 0.1256 | -0.3460 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 2 | D01 | 72 | hr | 1235 | 527 | 4578 | 0.1151 | -0.3631 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 3 | D01 | 72 | hr | 1235 | 827 | 4929 | 0.1678 | -0.1824 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 1235 | 1369 | 4474 | 0.3059 | 0.0566 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 2 | B18 | 72 | hr | 1235 | 1372 | 4578 | 0.2997 | 0.0568 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 1235 | 1406 | 4929 | 0.2852 | 0.0667 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 1235 | 1319 | 4474 | 0.2948 | 0.0357 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 2 | B17 | 72 | hr | 1235 | 1388 | 4578 | 0.3032 | 0.0633 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 3 | B17 | 72 | hr | 1235 | 1245 | 4929 | 0.2526 | 0.0037 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 1 | B16 | 72 | hr | 1235 | 1515 | 4474 | 0.3386 | 0.1159 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 1235 | 1383 | 4578 | 0.3021 | 0.0613 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 1235 | 1434 | 4929 | 0.2909 | 0.0773 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 1235 | 1341 | 4474 | 0.2997 | 0.0449 |